These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5187246)

  • 41. [Difficulties in the treatment of pulmonary tuberculosis in a patient rapidly inactivating isoniazid (INH)].
    Bednarski Z
    Wiad Lek; 1984 Jun; 37(12):937-40. PubMed ID: 6523868
    [No Abstract]   [Full Text] [Related]  

  • 42. [Results of complex chemotherapy of pulmonary tuberculosis using rapid intravenous injections of isoniazid].
    Kobeleva GV
    Probl Tuberk; 1983 Apr; (4):28-31. PubMed ID: 6866965
    [No Abstract]   [Full Text] [Related]  

  • 43. [Isoprodian in ambulatory therapy of pulmonary tuberculosis].
    Opl G; Novak M
    Prax Klin Pneumol; 1980 Dec; 34(12):715-8. PubMed ID: 7465531
    [No Abstract]   [Full Text] [Related]  

  • 44. The prognosis of pulmonary tuberculosis under modern treatment.
    Thomassen OK
    Scand J Respir Dis Suppl; 1968; 63():29-32. PubMed ID: 5188461
    [No Abstract]   [Full Text] [Related]  

  • 45. [Effectiveness of chemotherapy of chronic forms of pulmonary tuberculosis under hospital conditions].
    Kolesnikov VV; Mikhaĭlov VI; Matviiakina TS
    Probl Tuberk; 1980 Mar; (3):41-4. PubMed ID: 7393892
    [No Abstract]   [Full Text] [Related]  

  • 46. [Results of the ambulatory treatment of 50 pulmonary tuberculosis patients using myambutol and isoniazid].
    Briones Arellano E; Durand Nicola J
    Rev Ecuat Hig Med Trop; 1969; 26(1):81-4. PubMed ID: 5345519
    [No Abstract]   [Full Text] [Related]  

  • 47. [Results of controlled clinical trials of intensive isoniazid therapy].
    Utkin VV; Keleberda KIa; Karachunskiĭ MA
    Probl Tuberk; 1980 Jul; (7):22-7. PubMed ID: 6997866
    [No Abstract]   [Full Text] [Related]  

  • 48. [Results of short-term tuberculostatic treatment at the end of the therapeutic regimen].
    Tănase C; Baraneţchi C
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1983; 32(1):43-7. PubMed ID: 6312534
    [No Abstract]   [Full Text] [Related]  

  • 49. [Complex research studies in the testing of the effectiveness of phenaside].
    Sel'tsovskiĭ PP; Irtuganova OA; Slogotskaia LV; Smirnova NS; Moroz AM; Borzenko AS; Spasov AA; Smirnova LA; Dzhura PI; Karpov AV; Ivanovskiĭ VB; Pauker MN; Plemiannikova GI
    Probl Tuberk; 2001; (8):29-31. PubMed ID: 11767386
    [No Abstract]   [Full Text] [Related]  

  • 50. The rate of isoniazid inactivation in Finnish diabetic and non-diabetic patients.
    Mattila MJ; Tiitinen H
    Ann Med Exp Biol Fenn; 1967; 45(4):423-7. PubMed ID: 5599058
    [No Abstract]   [Full Text] [Related]  

  • 51. [Trial treatment of pulmonary tuberculosis with a combination of isoniazid and an injectable diphenylthiourea preparation].
    Chicou J; Hetrick G; Le Hir M; Mercier A; Neel R; Lambert C
    Maroc Med; 1967 Apr; 47(501):318-34. PubMed ID: 5619183
    [No Abstract]   [Full Text] [Related]  

  • 52. [Hematic concentrations of free isoniazid after rectal administration].
    Cassetti B; Pirolli T
    Ann Ist Carlo Forlanini; 1966; 26(4):508-13. PubMed ID: 5991602
    [No Abstract]   [Full Text] [Related]  

  • 53. [Observation on ambulant chemotherapy for primary treated cases of pulmonary tuberculosis (author's transl)].
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1979; 2(4):201-3. PubMed ID: 555426
    [No Abstract]   [Full Text] [Related]  

  • 54. [Comparative study of the treatment of pulmonary tuberculosis by a combination of rifampicin and isoniazid administered daily and twice weekly for a year].
    Decroix G; Kreis B; Sors C; Birenbaum J; Le Lirzin M; Canetti G
    Rev Tuberc Pneumol (Paris); 1971; 35(1):39-54. PubMed ID: 5559724
    [No Abstract]   [Full Text] [Related]  

  • 55. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].
    Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627
    [No Abstract]   [Full Text] [Related]  

  • 56. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
    Ahn HC; Lee YC
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The clinical and pharmacokinetic features of lymphotropic therapy in patients with new-onset pulmonary tuberculosis].
    Priakhina VN; Kolpakov MA; Kolpakov AR; Zyrianova TV; Mokhina OG
    Probl Tuberk Bolezn Legk; 2005; (6):55-8. PubMed ID: 16078725
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M; Bek E
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract]   [Full Text] [Related]  

  • 59. [Late treatment results in minor forms of pulmonary tuberculosis].
    Berezovskiĭ BA; Marchak VV; Shepetovskaia TA; Fleĭman FE
    Probl Tuberk; 1980 Aug; (8):34-6. PubMed ID: 7403047
    [No Abstract]   [Full Text] [Related]  

  • 60. [Intravenous method of chemotherapy of pulmonary tuberculosis].
    Rudoĭ NM; Utkin VV
    Probl Tuberk; 1969; 47(3):23-7. PubMed ID: 5354630
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.